Latest Strategy News

Core Lithium has unveiled an updated mine plan for its Grants deposit at the Finniss Lithium Project, increasing the Ore Reserve by 33% and cutting pre-production capital costs by up to $45 million.

Algorae Pharmaceuticals has launched AlgoraeOS Version 2, a major AI platform upgrade that surpasses leading models including those from Google DeepMind, promising to accelerate drug-combination discovery.

Sparc Technologies teams up with Dulux Australia to apply their graphene-enhanced ecosparc® coating on the heritage-listed Cape Jaffa Lighthouse, marking a key step in commercialising advanced protective coatings.

X2M Connect has secured over half a million Australian dollars in new and repeat water digitisation contracts in South Korea, driving strong early revenue growth in FY26. These deals expand the company’s footprint across thousands of households and highlight growing government adoption of IoT solutions.

Lightning Minerals reports strong assay results from its inaugural Mt Turner drilling campaign, confirming high-grade gold and base metals mineralisation and setting the stage for expanded exploration in 2026.

Integral Diagnostics has appointed Jason Martinez as its new CEO, set to lead the company’s growth and innovation efforts starting in 2026. Martinez brings over two decades of diagnostic imaging leadership experience, promising a strategic focus on expansion and operational excellence.

AGL Energy has agreed to divest 19.9% of its 20% stake in Tilt Renewables for $750 million, reinforcing its strategy to recycle capital and invest in flexible energy capacity while maintaining a strategic partnership.

Dyno Nobel Limited reported a robust 23% increase in EBIT for FY25, driven by strong explosives performance and transformation initiatives, while progressing its fertilisers separation and setting ambitious sustainability targets.

Dyno Nobel reported a modest revenue dip but a solid 5.6% rise in net profit excluding one-off items for FY25, completing key divestments and advancing its transformation program.

Count Limited reported robust FY2025 financial results marked by significant revenue and profit growth, underpinned by strategic acquisitions and organic expansion. The positive momentum continues into FY2026 Q1 with further gains and a solid M&A pipeline.

Count Limited reports robust FY25 financial results driven by successful acquisitions and organic growth, with promising momentum continuing into FY26. The company’s integrated accounting and wealth services model positions it well amid demographic and market trends.

Memphasys Limited has successfully raised over $1.1 million through a pro-rata entitlement offer to accelerate the commercialisation of its innovative Felix™ sperm selection system, targeting key regulatory approvals and market expansion.